In a bid to improve safety, the UK Government is considering a plan to introduce a new pneumococcus vaccine by the end of 2020.
The government hopes that the vaccine will help reduce the spread of the virus in adults, which is a concern as the number of cases has risen in recent months.
The new vaccine would be available to patients at the age of five and has been developed by researchers at the University of Oxford and the University in Birmingham.
The researchers said they hoped the vaccine could be ready by the beginning of 2020 to help protect children.
The vaccine is being developed to protect children from the pneumococci which causes the most common pneumonia.
In a report published this week, the academics said the vaccine would not protect against a third pneumococcell pneumonia which can be contracted from the respiratory tract.
However, the vaccine’s effectiveness against the second pneumonia could be enhanced if it could be administered as an aerosol.
Dr Peter Macfarlane, director of the Institute of Public Health and Infectious Disease at the London School of Hygiene and Tropical Medicine, said the pneumococcosis vaccine could help control the number and spread of pneumococca, a bacterium which can cause pneumonia.
He said pneumococcosis cases had risen significantly in recent years.
“It has been reported that about 50% of children under five have had their first pneumonia and about one in five have been hospitalised, so there is a high risk that the pneumocyst vaccine could make a difference,” Dr Macfaddin said.
He noted that a new vaccine for pneumococcoidosis was also being tested in Australia.
Dr Macp, who is also the director of medical and health services at the Royal Children’s Hospital, said that the coronavirus had become more serious in recent times and that there were now more cases than ever before.
“There’s a very clear and growing body of evidence that the pandemic has been very damaging to children and adults,” he said.
“So, if we have the right vaccine we might be able to get the population up to about 10 times more vaccinated than it was before the pandemics.”
He said that, as the pandems reached a peak, the public would benefit from being vaccinated, with the new vaccine likely to be as effective against the pandemia as against other diseases.